Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis.

Punch, Emily; Klein, Justus; Diaba-Nuhoho, Patrick; Morawietz, Henning; Garelnabi, Mahdi

Punch, Emily; Klein, Justus; Diaba-Nuhoho, Patrick; Morawietz, Henning; Garelnabi, Mahdi.

Afiliação

Punch E; Department of Chemistry University of Massachusetts Lowell MA.
Klein J; Division of Vascular Endothelium and Microcirculation Department of Medicine III University Hospital and Medical Faculty Carl Gustav CarusTechnische Universität Dresden Germany.
Diaba-Nuhoho P; Division of Vascular Endothelium and Microcirculation Department of Medicine III University Hospital and Medical Faculty Carl Gustav CarusTechnische Universität Dresden Germany.
Morawietz H; Division of Vascular Endothelium and Microcirculation Department of Medicine III University Hospital and Medical Faculty Carl Gustav CarusTechnische Universität Dresden Germany.
Garelnabi M; Biomedical and Nutritional Sciences University of Massachusetts Lowell MA.

J Am Heart Assoc ; 11(3): e023328, 2022 02.

Article em En | MEDLINE | ID: mdl-35048716

Assuntos

Aterosclerose; Doenças Cardiovasculares; Placa Aterosclerótica; Aterosclerose/metabolismo; Humanos; Inflamação/patologia; Pró-Proteína Convertase 9/metabolismo

Palavras-chave

PCSK9; atherosclerosis; inflammation; oxidation; resistin

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose / Placa Aterosclerótica Limite: Humans Idioma: En Revista: J Am Heart Assoc Ano de publicação: 2022 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google